Error: Could not add to watchlist. X
+ Watchlist

Conatus Pharmaceuticals Inc

CNAT:US
NASDAQ GM
2.04
USD
0.09
4.23%
As of 8:10 PM EDT 6/24/2016
Open
2.04
Day Range
1.94 - 2.09
Volume
117,934
Previous Close
2.13
52Wk Range
1.40 - 7.12
1 Yr Return
-62.43%
Open
2.04
Day Range
1.94 - 2.09
Volume
117,934
Previous Close
2.13
52Wk Range
1.40 - 7.12
1 Yr Return
-62.43%
YTD Return
-29.17%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-1.27
Market Cap (m USD)
43.344
Shares Outstanding (m)
21.247
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Conatus Pharmaceuticals, Inc. develops therapeutics to treat liver disease. The Company offers drugs to control programmed cell death that contributes to a range of liver diseases and cancer treatments. Conatus Pharmaceuticals provides its products in the United States.
Address
16745 West Bernardo Drive
Suite 200
San Diego, CA 92127
United States
Phone
1-858-376-2600
Show More